Mairéad Mcnamara

The University of Manchester

United Kingdom

Research Interests

Explore related searches

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (19)

Collaborators (8)

Julien Edeline

PU-PH - Full Professor

Université de Rennes 1 Faculté de Médecine

Aiwu He

Associate Professor

Georgetown University

UNITED STATES

Jack Gleeson

Associate Professor in Medical Oncology

Cork University Hospital

Juan W. Valle

The University of Manchester

UNITED KINGDOM

Debashis Sarker

King’s College London

UNITED KINGDOM

Jorge Barriuso

The University of Manchester

UNITED KINGDOM

jonathan wadsley

University of Sheffield

UNITED KINGDOM

Angela Lamarca

The University of Manchester

UNITED KINGDOM

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Mairéad Mcnamara

Research Interests

Explore related searches

Contact this professor

Articles (19)

Collaborators (8)

Julien Edeline

Aiwu He

Jack Gleeson

Juan W. Valle

Debashis Sarker

Jorge Barriuso

jonathan wadsley

Angela Lamarca

Make your next move.

Mairéad Mcnamara

Research Interests

Explore related searches

Contact this professor

Articles (19)

Intrahepatic Cholangiocarcinoma With Extrahepatic Metastasis and High Tumor Mutation Burden: Case of Complete Pathological Response to Cisplatin/Gemcitabine/Pembrolizumab

Systemic Therapy for Metastatic Pancreatic Cancer—Current Landscape and Future Directions

Third-Line Palliative Systemic Therapy for Advanced Biliary Tract Cancer: Multicentre Review of Patterns of Care and Outcomes

Prospective Observational Study of Prevalence, Assessment and Treatment of Pancreatic Exocrine Insufficiency in Patients with Inoperable Pancreatic Malignancy (PANcreatic Cancer Dietary Assessment—PanDA)

NET-02: a randomised, non-comparative, phase II trial of nal-IRI/5-FU or docetaxel as second-line therapy in patients with progressive poorly differentiated extra-pulmonary neuroendocrine carcinoma

Patients Undergoing Systemic Anti-Cancer Therapy Who Require Surgical Intervention: What Surgeons Need to Know

Targeting PD-1/PD-L1 in biliary tract cancer; role and available data

Relevant Study: Patient and Clinician Perspectives on Clinically-Meaningful Outcomes in Advanced Pancreatic Cancer

Resistance mechanism to fibroblast growth factor receptor (FGFR) inhibitors in cholangiocarcinoma

Influence of cirrhosis on outcomes of patients with advanced intrahepatic cholangiocarcinoma receiving chemotherapy

Selection of Chemotherapy in Advanced Poorly Differentiated Extra-Pulmonary Neuroendocrine Carcinoma

Prognosis Discussion and Referral to Community Palliative Care Services in Patients with Advanced Pancreatic Cancer Treated in a Tertiary Cancer Centre

Current Evidence for Immune Checkpoint Inhibition in Advanced Hepatocellular Carcinoma

Choosing the best systemic treatment sequence for control of tumour growth in gastro-enteropancreatic neuroendocrine tumours (GEP-NETs): what is the recent evidence?

Plain language summary of the TOPAZ-1 study

Randomised, Phase II study of selumetinib, an oral inhibitor of MEK, in combination with cisplatin and gemcitabine chemotherapy for patients with advanced biliary tract cancer

What is the gender representation in authorship in later phase systemic clinical trials in biliary tract cancer (BTC)? - a retrospective review of the published literature

Use of the Rockwood Clinical Frailty Scale in patients with advanced hepatopancreaticobiliary malignancies

The Management and Outcomes of Patients with Extra-Pulmonary Neuroendocrine Neoplasms and Brain Metastases

Collaborators (8)

Julien Edeline

Aiwu He

Jack Gleeson

Juan W. Valle

Debashis Sarker

Jorge Barriuso

jonathan wadsley

Angela Lamarca

Make your next move.